Neuroblastoma, Version 2.2024

Rochelle Bagatell; Julie R. Park; Sahaja Acharya; Jennifer Aldrink; Jenna Allison; Elizabeth Alva; Carola Arndt; Daniel Benedetti; Erin Brown; Steve Cho; Alanna Church; Andrew Davidoff; Ami V. Desai; Steven DuBois; Douglas Fair; Joaquim Farinhas; Douglas Harrison; Frederick Huang; Paul Iskander; Susan Kreissman; Margaret Macy; Brian Na; Farzana Pashankar; Praveen Pendyala; Navin Pinto; Stephanie Polites; Raja Rabah; Hiroyuki Shimada; Leonora Slatnick; Elizabeth Sokol; Clare Twist; Kieuhoa Vo; Tanya Watt; Suzanne Wolden; Peter Zage; Ryan Schonfeld; Lisa Hang

doi:10.6004/jnccn.2024.0040

Neuroblastoma, Version 2.2024

Rochelle Bagatell, Julie R. Park, Sahaja Acharya, Jennifer Aldrink, Jenna Allison, Elizabeth Alva, Carola Arndt, Daniel Benedetti, Erin Brown, Steve Cho, Alanna Church, Andrew Davidoff, Ami V. Desai, Steven DuBois, Douglas Fair, Joaquim Farinhas, Douglas Harrison, Frederick Huang, Paul Iskander, Susan KreissmanMargaret Macy, Brian Na, Farzana Pashankar, Praveen Pendyala, Navin Pinto, Stephanie Polites, Raja Rabah, Hiroyuki Shimada, Leonora Slatnick, Elizabeth Sokol, Clare Twist, Kieuhoa Vo, Tanya Watt, Suzanne Wolden, Peter Zage, Ryan Schonfeld, Lisa Hang

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

Original language	English (US)
Pages (from-to)	413-433
Number of pages	21
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2024.0040
State	Published - Aug 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2024.0040

Cite this

Bagatell, R., Park, J. R., Acharya, S., Aldrink, J., Allison, J., Alva, E., Arndt, C., Benedetti, D., Brown, E., Cho, S., Church, A., Davidoff, A., Desai, A. V., DuBois, S., Fair, D., Farinhas, J., Harrison, D., Huang, F., Iskander, P., ... Hang, L. (2024). Neuroblastoma, Version 2.2024. JNCCN Journal of the National Comprehensive Cancer Network, 22(6), 413-433. https://doi.org/10.6004/jnccn.2024.0040

Bagatell, R, Park, JR, Acharya, S, Aldrink, J, Allison, J, Alva, E, Arndt, C, Benedetti, D, Brown, E, Cho, S, Church, A, Davidoff, A, Desai, AV, DuBois, S, Fair, D, Farinhas, J, Harrison, D, Huang, F, Iskander, P, Kreissman, S, Macy, M, Na, B, Pashankar, F, Pendyala, P, Pinto, N, Polites, S, Rabah, R, Shimada, H, Slatnick, L, Sokol, E, Twist, C, Vo, K, Watt, T, Wolden, S, Zage, P, Schonfeld, R & Hang, L 2024, 'Neuroblastoma, Version 2.2024', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 6, pp. 413-433. https://doi.org/10.6004/jnccn.2024.0040

@article{fd8df5b45c2f4465bfe13fbd59bc165d,

title = "Neuroblastoma, Version 2.2024",

abstract = "Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.",

author = "Rochelle Bagatell and Park, {Julie R.} and Sahaja Acharya and Jennifer Aldrink and Jenna Allison and Elizabeth Alva and Carola Arndt and Daniel Benedetti and Erin Brown and Steve Cho and Alanna Church and Andrew Davidoff and Desai, {Ami V.} and Steven DuBois and Douglas Fair and Joaquim Farinhas and Douglas Harrison and Frederick Huang and Paul Iskander and Susan Kreissman and Margaret Macy and Brian Na and Farzana Pashankar and Praveen Pendyala and Navin Pinto and Stephanie Polites and Raja Rabah and Hiroyuki Shimada and Leonora Slatnick and Elizabeth Sokol and Clare Twist and Kieuhoa Vo and Tanya Watt and Suzanne Wolden and Peter Zage and Ryan Schonfeld and Lisa Hang",

year = "2024",

month = aug,

doi = "10.6004/jnccn.2024.0040",

language = "English (US)",

volume = "22",

pages = "413--433",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "6",

}

TY - JOUR

T1 - Neuroblastoma, Version 2.2024

AU - Bagatell, Rochelle

AU - Park, Julie R.

AU - Acharya, Sahaja

AU - Aldrink, Jennifer

AU - Allison, Jenna

AU - Alva, Elizabeth

AU - Arndt, Carola

AU - Benedetti, Daniel

AU - Brown, Erin

AU - Cho, Steve

AU - Church, Alanna

AU - Davidoff, Andrew

AU - Desai, Ami V.

AU - DuBois, Steven

AU - Fair, Douglas

AU - Farinhas, Joaquim

AU - Harrison, Douglas

AU - Huang, Frederick

AU - Iskander, Paul

AU - Kreissman, Susan

AU - Macy, Margaret

AU - Na, Brian

AU - Pashankar, Farzana

AU - Pendyala, Praveen

AU - Pinto, Navin

AU - Polites, Stephanie

AU - Rabah, Raja

AU - Shimada, Hiroyuki

AU - Slatnick, Leonora

AU - Sokol, Elizabeth

AU - Twist, Clare

AU - Vo, Kieuhoa

AU - Watt, Tanya

AU - Wolden, Suzanne

AU - Zage, Peter

AU - Schonfeld, Ryan

AU - Hang, Lisa

PY - 2024/8

Y1 - 2024/8

N2 - Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

AB - Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.

UR - http://www.scopus.com/inward/record.url?scp=85201577531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85201577531&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0040

DO - 10.6004/jnccn.2024.0040

M3 - Article

C2 - 39151455

AN - SCOPUS:85201577531

SN - 1540-1405

VL - 22

SP - 413

EP - 433

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Neuroblastoma, Version 2.2024

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this